S&P 500 7,663.43 −1.21%
Nasdaq 26,008.86 −2.60%
S&P/TSX 35,973.45 −0.97%
Apple 348.22 +1.23%
Nvidia 212.21 −4.40%
Microsoft 521.08 −2.23%
Shopify 236.41 −3.48%
Royal Bank 282.78 −0.30%
CAD/USD 0.7136 +0.20%
PRE-MKT · 04:25 ET
Market ClerkRecap
Fri Oct 23 · pre-market6 signals on Oct 22103 insider buys this week · $208.8MCIRO short report next: Oct 31The week ahead

ANAB

ANAPTYSBIO, INC
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
48.10
+0.16 +0.33%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $1.4BP/E 8.4DIV YIELD —FCF YIELD —REV TTM $237.6M +92.9%NET INCOME $195.7MNET CASH —52W 22.06 – 69.81NEXT EARNINGS Nov 3 EST.SEC XBRL · TTM TO Invalid Date

What ANAB had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Sep 21ExhibitsSep 21open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch ANAB. Know when insiders buy.
One email the day a filing lands. Free.